Furthermore, CD56 expression in LCC was associated with inferior disease-free survival, while synaptophysin positivity in LCNEC correlated with worse overall survival despite adjuvant chemotherapy. Here, NCAM1 is linked to large cell neuroendocrine carcinoma.